Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:4-(\{4-[(6-chloronaphthalen-2-yl)sulfonyl]-2-oxopiperazin-1-yl\}methyl)-1-pyridin-4-ylpiperidine-4-carbaldehyde oxime
go back to main search page
Accession:CHEBI:47746 term browser browse the term
Definition:A pyridylpiperidine that has formula C26H28ClN5O4S.


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19679
    chemical entity 19677
      atom 19675
        nonmetal atom 19540
          carbon atom 19430
            organic molecular entity 19430
              oxime 173
                aldoxime 79
                  4-(\{4-[(6-chloronaphthalen-2-yl)sulfonyl]-2-oxopiperazin-1-yl\}methyl)-1-pyridin-4-ylpiperidine-4-carbaldehyde oxime 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19679
    subatomic particle 19675
      composite particle 19675
        hadron 19675
          baryon 19675
            nucleon 19675
              atomic nucleus 19675
                atom 19675
                  main group element atom 19555
                    p-block element atom 19555
                      chalcogen 19242
                        oxygen atom 19196
                          oxygen molecular entity 19196
                            hydroxides 18973
                              oxoacid 18084
                                chalcogen oxoacid 11400
                                  sulfur oxoacid 10990
                                    sulfonic acid 7240
                                      sulfonic acid derivative 7240
                                        sulfonamide 3126
                                          N-sulfonylpiperazine 38
                                            4-(\{4-[(6-chloronaphthalen-2-yl)sulfonyl]-2-oxopiperazin-1-yl\}methyl)-1-pyridin-4-ylpiperidine-4-carbaldehyde oxime 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.